J. Peterse

J. Peterse, E. Rutgers, L. Broekhuizen, 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Diagnostic accuracy for different strategies of image-guided breast intervention in cases of nonpalpable breast lesions

R Holland, J. Peterse, W. Mali, 2004, British Journal of Cancer.

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

J. Peterse, M. Vijver, A. Cleton-Jansen, 1999, British Journal of Cancer.

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2003, British Journal of Cancer.

The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study

J. Peterse, H. Bartelink, J. Wesseling, 2009, Breast Cancer Research and Treatment.

Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis.

Kenneth G A Gilhuijs, J. Peterse, E. Rutgers, 2005, European journal of cancer.

CHAPTERR NINE Frozenn Section Investigation of the Sentinell Node in Malignant Melanoma andd Breast Cancer

J. Peterse, P. Tanis, R. P. Boom, 2022 .

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

A. Hart, J. Peterse, E. Rutgers, 2003, British Journal of Cancer.

Prognostic value of DNA ploidy using flow cytometry in 1301 breast cancer patients: results of the prospective Multicenter Morphometric Mammary Carcinoma Project.

J. Peterse, P. V. van Diest, J. Baak, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union—an inter-laboratory study

J. Peterse, I. Ellis, C. Elston, 2004, Virchows Archiv.

Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes

J. Peterse, E. Rutgers, H. Oldenburg, 2006, Cancer.

CSF cytology versus immunocytochemistry in meningeal carcinomatosis.

J. Peterse, P. Heerde, W. Boogerd, 1988, Journal of neurology, neurosurgery, and psychiatry.

Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.

A. Gad, J. Peterse, C. Elston, 1998, Human pathology.

Progress in molecular biology of breast cancer.

J. Peterse, W. Mooi, 1992, European journal of cancer.

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

M. J. van de Vijver, J. Peterse, P. Devilee, 1994, Cancer research.

Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study

J. Peterse, A. Sapino, S. Bianchi, 2007, Pathology & Oncology Research.

Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients

J. Peterse, E. Rutgers, E. Rutgers, 2002, British Journal of Cancer.

False negative sentinel node procedure established through palpation of the biopsy wound.

J. Peterse, P. Tanis, O. Nieweg, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer.

M. J. van de Vijver, J. Peterse, J. Coebergh, 2005, European journal of cancer.

Third meeting of the DCIS Working Party of the EORTC (Fondazione Cini, Isola S. Giorgio, Venezia, 28 February 1994)--Conference report.

J. Peterse, I. Fentiman, A. Recht, 1994, European journal of cancer.

Ductal carcinoma in-situ of the breast; second EORTC consensus meeting.

J. Peterse, I. Fentiman, A. Recht, 1992, European journal of cancer.

Impact of mammographic interval on stage and survival after the diagnosis of contralateral breast cancer

J. Peterse, A. A. Hart, A. Besnard, 2001, The British journal of surgery.

Squamous Cell Carcinoma In Situ of the Breast: A Light Microscopic and Immunohistochemical Study of a Previously Undescribed Lesion

J. Peterse, V. Eusebi, M. Hayes, 2007, The American journal of surgical pathology.

Lobular Carcinoma of the Breast With Hybrid Myoepithelial and Secretory (“Myosecretory”) Cell Differentiation

J. Peterse, V. Eusebi, M. Foschini, 2005, The American journal of surgical pathology.

Breast conserving therapy in patients with relatively large (T2, T3) breast cancers by preoperative irradiation and myocutaneous LD flap reconstruction. A new technique in breast conservation.

J. Peterse, H. Bartelink, E. Rutgers, 1993, European journal of cancer.

Impact of a boost dose of 16 GY on the local control and cosmesis in patients with early breast cancer: The EORTC ‘boost versus no boost’ trial

J. Peterse, H. Bartelink, J. Horiot, 2000 .

Increased proliferative activity and p53 expression in normal glandular breast tissue after radiation therapy

J. Peterse, J. Jager, J. D. de Jong, 1998, Journal of Pathology.

IN-SITU BREAST CANCER: THE EORTC CONSENSUS MEETING

J. Peterse, I. Fentiman, J. Harris, 1989, The Lancet.

Validation of clinical prediction rules for a low probability of nonsentinel and extensive lymph node involvement in breast cancer patients.

J. Peterse, A. Sapino, S. Bianchi, 2007, American journal of surgery.

Clinical surgery-International Validation of clinical prediction rules for a low probability of nonsentinel and extensive lymph node involvement in breast cancer patients

J. Peterse, A. Sapino, S. Bianchi, 2007 .

Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer.

L J Schultze Kool, S H Muller, J. Peterse, 2003, European journal of cancer.

Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA.

M. J. van de Vijver, J. Peterse, R. Nusse, 1988, Oncogene.

Amplification and over-expression of the neu oncogene in human breast carcinomas.

M. J. van de Vijver, J. Peterse, R. Nusse, 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].

C. de Wolf, A. Gad, J. Peterse, 1997, Der Pathologe.

Fine needle aspiration cytology of radiation-induced changes in nonneoplastic breast lesions. Possible pitfalls in cytodiagnosis.

J. Peterse, F. Thunnissen, P. van Heerde, 1989, Acta cytologica.

Breast-conserving therapy ‘avant la lettre’: a long-term follow-up study after radical partial mastectomy and low-dose orthovoltage irradiation for stage I and II breast cancer

J. Peterse, J. Borger, H. Kemperman, 1998 .

Lymphoepithelioma‐like carcinoma of the breast: lack of evidence of Epstein–Barr virus infection

J. Peterse, A. Sapino, V. Eusebi, 2001, Histopathology.

Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description

J. Peterse, Christine Betts, R. Golouh, 2002, Virchows Archiv.

TPS3, Is targeted by LOH on lip in some breast tumors and that a substantial number of breast tumors stabilize p53 through mechanisms

M. J. van de Vijver, J. Peterse, P. Devilee, 2006 .

Adult Pelvic Sarcomas: A Heterogeneous Collection of Sarcomas?

J. Peterse, F. van Coevorden, C. Keyzer-Dekker, 2004, Sarcoma.

Cytodiagnosis of non-Hodgkin's lymphoma

J. Peterse, P. Heerde, M. A. Koolman-Schellekens, 1984, Virchows Archiv A.

Recurrence of breast carcinoma after breast conserving treatment.

J. Peterse, H. Bartelink, J. V. Dongen, 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Polyploidy In Pleomorphic Adenomas With Cytological Atypia

J. Peterse, F. Bosman, F. Thunnissen, 1992, Cytopathology : official journal of the British Society for Clinical Cytology.

Acinic cell carcinoma of the breast: an immunohistochemical and ultrastructural study

J. Peterse, V. Eusebi, G. Pasquinelli, 2000, Virchows Archiv.

Sex steroid receptor expression in ‘carcinoid’ tumours of the breast

J. Peterse, T. Kwast, P. J. Janssen, 1996, Breast Cancer Research and Treatment.

Expression of oestrogen receptor and loss of E‐cadherin are diagnostic for gastric metastasis of breast carcinoma

J. Peterse, M. V. van Velthuysen, J. J. van der Hoeven, 2005, Histopathology.

Monoclonal Antibodies in Breast Tumor Pathology.

J. Peterse, J. Hilkens, J. Hilgers, 1987 .

New Approaches to the Pathology of Breast Cancer; Can Immunohistochemistry Add New Information?

J. Peterse, P. Hageman, 1986 .

Adenomyoepithelioma of the breast associated with low-grade adenosquamous and sarcomatoid carcinomas

J. Peterse, V. Eusebi, M. Foschini, 2004, Virchows Archiv.

Breast-conserving treatment with or without radiotherapy for ductal carcinoma in situ (DCIS): ten-year results of European Organisation for Research and Treatment of Cancer (EORTC) randomized phase III trial 10853

J. Peterse, J. Bogaerts, N. Bijker, 2006 .

Local recurrence of a phyllodes tumour of the breast presenting with widespread differentiation to a telangiectatic osteosarcoma.

J. Peterse, H. Zonderland, P. Hogendoorn, 1998, Journal of clinical pathology.

Solitary fibrous tumour (myofibroblastoma) of the breast

J. Peterse, V. Eusebi, M. Miettinen, 2004, Virchows Archiv.

A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy.

A. Hart, J. Peterse, E. Rutgers, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Microcalcifications in ductal carcinoma in situ of the breast: histochemical and immunohistochemical study.

J. Peterse, V. Eusebi, A. Fornelli, 1996, Human pathology.

Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas

A. Gad, J. Peterse, C. Elston, 1999, Virchows Archiv.

Clear cell sarcoma (malignant melanoma) of soft parts

J. Peterse, E. Rutgers, A. A. Hart, 1999, Cancer.

Ductal carcinoma in situ: a proposal for a new classification.

M. J. van de Vijver, J. Peterse, M. Vijver, 1994, Seminars in diagnostic pathology.

Breast‐conserving therapy for paget disease of the nipple

J. Peterse, E. Rutgers, J. Julien, 2001, Cancer.

Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition?

J. Peterse, E. Rutgers, F. van Coevorden, 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

Jos Jonkers, Robert D Cardiff, Bastiaan Evers, 2006, Cancer cell.

Accuracy of fine‐needle aspiration cytology of salivary gland lesions in the netherlands cancer institute

J. Peterse, M. V. van Velthuysen, A. Balm, 2004, Head & neck.

M. J. van de Vijver, J. Peterse, G. Berx, 2022 .

Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.

M. J. van de Vijver, J. Peterse, O. Dalesio, 1988, The New England journal of medicine.

Association of C‐MYC amplification with progression from the in situ to the invasive stage in C‐MYC‐amplified breast carcinomas

M. J. van de Vijver, A. Hart, J. Peterse, 2003, The Journal of pathology.

Prognostic Significance of Macrophage Infiltration in Leiomyosarcomas

Robert J. Marinelli, R. West, M. Rijn, 2008, Clinical Cancer Research.

Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ

M. J. van de Vijver, J. Peterse, G. Berx, 1997, The Journal of pathology.

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer.

M. J. van de Vijver, J. Peterse, P. Devilee, 1992, Cancer research.

Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene

M. J. van de Vijver, J. Peterse, R. Nusse, 1987, Molecular and cellular biology.

Classification of ductal carcinoma in situ by gene expression profiling

M. J. van de Vijver, J. Peterse, B. Kreike, 2006, Breast Cancer Research.

DCIS: Pathology and Molecular Markers

M. J. van de Vijver, J. Peterse, M. Vijver, 2006 .

Changing patterns in diagnosis and treatment of ductal carcinoma in situ of the breast.

J. Peterse, E. Rutgers, H. Oldenburg, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.

J. Peterse, S. Moss, C. Elston, 2000, European journal of cancer.

Malignant neoplasms infiltrating pseudoangiomatous’ stromal hyperplasia of the breast: an unrecognized pathway of tumour spread

J. Peterse, V. Eusebi, S. Damiani, 2002, Histopathology.

Localizing the sentinel node in cutaneous melanoma: Gamma probe detection versus blue dye

Alfons J. M. Balm, Renato A. Valdés Olmos, Omgo E. Nieweg, 1997, Annals of Surgical Oncology.

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials.

J. Peterse, H. Bartelink, R. Sylvester, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mammographically detected in situ lobular carcinomas of the breast

J. Peterse, A. Sapino, G. Bussolati, 2000, Virchows Archiv.

Reliability of Fine Needle Aspiration Cytology For Distinguishing Between Carcinoma, Lymphoma and Sarcoma; the Influence of Clinical Information

J. Peterse, J. Arends, F. Thunnissen, 1993, Cytopathology : official journal of the British Society for Clinical Cytology.

Gene expression profiles of primary breast tumors maintained in distant metastases

Annuska M Glas, J. Peterse, A. Witteveen, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Complications after colorectal surgery without mechanical bowel preparation.

J. Peterse, R. P. Boom, L. Noach, 2002, Journal of the American College of Surgeons.

Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation.

J. Peterse, A. Broeks, R. Tollenaar, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.

J. Peterse, H. Bartelink, E. Rutgers, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.

J. Peterse, H. Bartelink, I. Fentiman, 1999, European journal of cancer.

Sentinel lymph node biopsy and non-sentinel node involvement in special type breast carcinomas with a good prognosis.

J. Peterse, A. Sapino, S. Bianchi, 2007, European journal of cancer.

Predicting Early Failure after Adjuvant Chemotherapy in High-Risk Breast Cancer Patients with Extensive Lymph Node Involvement

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2004, Clinical Cancer Research.

Randomized trial of high-dose chemotherapy and hematopoietic progenitor-cell support in operable breast cancer with extensive lymph node involvement: final analysis with 7 years of follow-up.

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

J. Peterse, S. Rodenhuis, J. Baars, 1998, The Lancet.

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853

J. Peterse, H. Bartelink, I. Fentiman, 2000, The Lancet.

Breast cancer: a study into the value of a historical group as comparative material for new methods of treatment.

A. Hart, J. Peterse, M. Hooning, 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Lymphatic mapping and sentinel lymph node biopsy in breast cancer

Liesbeth Jansen, Renato A. Valdés Olmos, Omgo E. Nieweg, 1999, European Journal of Nuclear Medicine.

Downstaging of an Advanced Gastrointestinal Stromal Tumor by Neoadjuvant Imatinib

J. Peterse, S. Rodenhuis, R. van Hillegersberg, 2004, Digestive Surgery.

The Value of Cloquet’s Node in Predicting Melanoma Nodal Metastases in the Pelvic Lymph Node Basin

A. Hart, J. Peterse, T. Wobbes, 2001, Annals of Surgical Oncology.

Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen

J. Peterse, A. Glas, L. Delahaye, 2008, Breast Cancer Research and Treatment.

Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines.

J. Peterse, I. Ellis, C. Elston, 2003, European journal of cancer.

Leiomyosarcomas Prognostic Significance of Macrophage Infiltration in Updated

Robert J. Marinelli, R. West, J. Peterse, 2008 .

Alveolar soft part sarcoma. a report of 15 cases.

J. Peterse, F. van Coevorden, B. Kroon, 2002, European journal of cancer.

Riskk factors for recurrence and metastasi s after breast-conservingg therapy for ductal carcinoma in situ;; analysis of EORTC tria l 10853

J. Peterse, 2008 .

Breast-conserving therapy for ductal carcinoma in situ Bijker

J. Peterse, 2008 .

The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls

A. Hart, J. Peterse, S. Muller, 2006, European Radiology.

The impact of tumor size and histology on local control after breast-conserving therapy.

J. Peterse, H. Bartelink, J. V. Dongen, 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reliability of sentinel lymph node biopsy for staging melanoma

J. Peterse, O. Nieweg, B. Kroon, 2000, The British journal of surgery.

Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results

Johan L. Bloem, Rob A. E. M. Tollenaar, J. Peterse, 2003, European Radiology.

Ultrasonography and Fine-needle Aspiration Cytology in the Preoperative Evaluation of Melanoma Patients Eligible for Sentinel Node Biopsy

J. Peterse, O. Nieweg, B. Kroon, 2006, Annals of Surgical Oncology.

Ultrasonography and Fine-Needle Aspiration Cytology Can Spare Breast Cancer Patients Unnecessary Sentinel Lymph Node Biopsy

J. Peterse, E. Rutgers, E. Deurloo, 2006, Annals of Surgical Oncology.

Is Lymphatic Mapping in Breast Cancer Adequate and Safe?

J. Peterse, E. Rutgers, O. Nieweg, 2001, World Journal of Surgery.

Frozen Section Investigation of the Sentinel Node in Malignant Melanoma and Breast Cancer

Omgo E. Nieweg, J. Peterse, E. Rutgers, 2001, Annals of Surgical Oncology.

Precise correlation between MRI and histopathology - exploring treatment margins for MRI-guided localized breast cancer therapy.

Roland Holland, Claudette E Loo, Harry Bartelink, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology

J. Peterse, I. Ellis, C. Elston, 2004, Journal of Clinical Pathology.

Malignant schwannoma of the parapharyngeal space in von Recklinghausen's disease: a case report and review of the literature

J. Peterse, F. Hilgers, A. Balm, 1993, The Journal of Laryngology & Otology.

SY-1-4 P53 mutations and other genetic changes in invasive and intraductal breast cancer

J. Peterse, M. Vijver, P. Clahsen, 1996 .

Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)

M. J. van de Vijver, J. Peterse, J. Coebergh, 1999, European journal of cancer.

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.

M. J. van de Vijver, J. Peterse, S. Rodenhuis, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunohistochemical categorisation of ductal carcinoma in situ of the breast

M. J. van de Vijver, J. Peterse, E. Rutgers, 2007, British Journal of Cancer.

Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients

J. Peterse, H. Bartelink, E. Rutgers, 2006, European Radiology.

Breast-conserving therapy for invasive carcinoma: diagnosis of local recurrence.

J. Peterse, E. Rutgers, J. Borger, 1991, The Netherlands journal of surgery.

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in ‘pure’ ductal carcinoma in situ of the breast

J. Peterse, J. Wesseling, M. D. de Roos, 2007, Histopathology.

The expression pattern of MUC 1 ( EMA ) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma

J. Peterse, J. Wesseling, C. Patriarca, 2007 .

Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy

A. Hart, J. Peterse, E. Rutgers, 1999, Cancer.

Interobserver variability between general and expert pathologists during the histopathological assessment of large-core needle and open biopsies of non-palpable breast lesions.

R Holland, J. Peterse, I. B. Borel Rinkes, 2003, European journal of cancer.

Reply to J. Staples

J. Peterse, H. Bartelink, J. Borger, 1989 .

Clinical Outcome after Selective Treatment of Patients Diagnosed with Ductal Carcinoma In Situ of the Breast

J. Peterse, H. Bartelink, E. Rutgers, 2007, Annals of Surgical Oncology.

Ductal Carcinoma in Situ of the Breast; Diagnostic Assessment and Treatment

J. Peterse, E. Rutgers, N. Bijker, 2002, Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society.

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: Absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism

J. Peterse, M. Schmidt, A. Cleton-Jansen, 2008, BMC Cancer.

[In-situ ductal carcinoma of the breast; a retrospective clinico-pathological study].

J. Peterse, P. Cohen, J. van Dongen, 1986, Nederlandsch tijdschrift voor geneeskunde.

CHAPTER 2 GANGLIOCYTIC PARAGANGLIOMA OF THE APPENDIX

J. Peterse, J. Blaauwgeers, G. Offerhaus, 2009 .

Clinically and mammographically occult breast lesions on MR images: potential effect of computerized assessment on clinical reading.

Kenneth G A Gilhuijs, J. Peterse, E. Deurloo, 2005, Radiology.

Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.

A. Hart, J. Peterse, H. Bartelink, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary axillary radiotherapy as axillary treatment in breast‐conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes

A. Hart, J. Peterse, F. Hoebers, 2000, Cancer.

Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations

J. Peterse, H. Verkooijen, M. V. Heiden, 2008, Breast Cancer Research and Treatment.

Eight false negative sentinel node procedures in breast cancer: what went wrong?

J. Peterse, E. Rutgers, O. Nieweg, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The relationship between findings on pre-treatment mammograms and local recurrence after breast-conserving therapy for invasive breast cancer.

J. Peterse, J. Coebergh, O. J. Repelaer van Driel, 1999, European Journal of Surgical Oncology.

Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.

J. Peterse, E. Rutgers, O. Nieweg, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

J. Peterse, S. Rodenhuis, J. Baars, 1996, British Journal of Cancer.

Feasibility study of FEC-chemotherapy with dose-intensive epirubicin as initial treatment in high-risk breast cancer.

J. Peterse, S. Rodenhuis, D. Richel, 1993, Annals of Oncology.

Radiation Induced Changes in Non-Neoplastic Breast Epithelium. A Possible Pitfall in Cytodiagnosis

J. Peterse, P. Heerde, 1986 .

Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core‐needle biopsy

J. Peterse, H. Oldenburg, C. Loo, 2007, The British journal of surgery.

[Young adults with Ewing's sarcoma].

J. Peterse, S. Linn, F. van Coevorden, 2004, Nederlands tijdschrift voor geneeskunde.

The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma

J. Peterse, J. Wesseling, B. van der Vegt, 2007, Histopathology.

Recurrence after breast ablation for ductal carcinoma in situ.

J. Peterse, J. van Dongen, E. de Jong, 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].

J. Peterse, E. Rutgers, O. Nieweg, 2004, Nederlands tijdschrift voor geneeskunde.

Clear cell sarcoma (malignant melanoma) of soft parts

J. Peterse, E. Rutgers, A. A. Hart, 1999, Cancer.

Refinement of breast cancer classification by molecular characterization of histological special types

J. Peterse, B. Kreike, D. de Jong, 2008, The Journal of pathology.

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

M. Marton, S. Friend, M. J. van de Vijver, 2002 .

A gene-expression signature as a predictor of survival in breast cancer.

Van, M. Marton, S. Friend, 2002, The New England journal of medicine.

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

L Duchateau, M. J. van de Vijver, J. Peterse, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.